Given the limiting dilution assay (LDA) is a well-established approach to accurately measure CSCs self-renewal capacity and tumorigenicity [35], we conducted the LDA to evaluate whether silence of MACC1 could impair non-CSCs dedifferentiation process by inhibiting tumorigenicity of xenograft-derived tumor cells. The gene discussed is MACC1; the disease is neoplasm.